Feasibility and advantages of delivering radiofrequency ablation treatment for haemorrhoids under local anaesthesia in the outpatient setting in the UK: our initial experience

INTRODUCTION: Radiofrequency ablation (RFA) for haemorrhoids has emerged as a minimally invasive treatment for grade II-III haemorrhoids, offering reduced postoperative pain and faster recovery compared with conventional surgery. However, most published data describe the procedure in theatre under general anaesthesia, limiting accessibility and increasing costs. METHODS: system with proctoscopy. The primary outcome was the successful completion of procedure as outpatient. Secondary outcomes were resolution of symptoms and improvement of quality of life. These were assessed using the Haemorrhoid Symptom Score (HSS) and EuroQol Visual Analogue Scale (EQ-VAS) at 2-4 and 12 months. RESULTS: In total, 53 patients were included in the study with median age of 58 years. A total of 33.9% of patients were ASA 3/4; seven of these patients were on anticoagulants, and their medications were stopped according to the British Society of Gastroenterology (BSG) guidelines. All the patients were able to complete the procedure under local anaesthetic in outpatient setting. All procedures were completed under local anaesthesia with same-day discharge and no major complications. Median follow up was 135 days. At 2-4 months, significant improvement in HSS was observed (mean difference 9.50; 95% CI 5.34-13.66; p < 0.001). The 12-month findings (n = 11) suggested possible persistence of benefit but are limited by substantial attrition and symptom-driven follow-up and should not be generalised. The quality-of-life scores (EQ-VAS) showed a 63% improvement between preoperative and 2-4-month values (p < 0.001). No statistically significant improvement was observed at 12 months within the remits of a small symptom-selected sample (n = 11). In total, six patients (11.3%) required subsequent operative intervention. None of the patients who were on anticoagulants had any bleeding complications or any unplanned return to tertiary care. CONCLUSIONS: Our experience demonstrates that radiofrequency ablation treatment for haemorrhoids can be safely and effectively delivered in an outpatient setting under local anaesthesia, even among higher-risk patients. The study demonstrates encouraging short-term symptom improvement, but the limited and selective long-term data preclude firm conclusions regarding durability or broader service impact. Larger, controlled studies with structured long-term follow-up are required to define the role of outpatient RFA within haemorrhoid care pathways.

Authors

Institutions

Publication Details

Journal
Techniques in Coloproctology
Published
2026-05-12
DOI
https://doi.org/10.1007/s10151-026-03353-1
Primary Topic
Anorectal Disease Treatments and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Feasibility and advantages of delivering radiofrequency ablation treatment for haemorrhoids under local anaesthesia in the outpatient setting in the UK: our initial experience

Aseef Yehiyan, Ashwin Rajendiran, Adam Daniel Gerrard, Simone Becker et al.
Techniques in Coloproctology
Anorectal Disease Treatments and Outcomes
article

Feasibility and advantages of delivering radiofrequency ablation treatment for haemorrhoids under local anaesthesia in the outpatient setting in the UK: our initial experience

Aseef Yehiyan, Ashwin Rajendiran, Adam Daniel Gerrard, Simone Becker, Chloe Thompson, Rajaganeshan Rajasundaram, Anjali Maharjan
article en

Abstract

INTRODUCTION: Radiofrequency ablation (RFA) for haemorrhoids has emerged as a minimally invasive treatment for grade II-III haemorrhoids, offering reduced postoperative pain and faster recovery compared with conventional surgery. However, most published data describe the procedure in theatre under general anaesthesia, limiting accessibility and increasing costs. METHODS: system with proctoscopy. The primary outcome was the successful completion of procedure as outpatient. Secondary outcomes were resolution of symptoms and improvement of quality of life. These were assessed using the Haemorrhoid Symptom Score (HSS) and EuroQol Visual Analogue Scale (EQ-VAS) at 2-4 and 12 months. RESULTS: In total, 53 patients were included in the study with median age of 58 years. A total of 33.9% of patients were ASA 3/4; seven of these patients were on anticoagulants, and their medications were stopped according to the British Society of Gastroenterology (BSG) guidelines. All the patients were able to complete the procedure under local anaesthetic in outpatient setting. All procedures were completed under local anaesthesia with same-day discharge and no major complications. Median follow up was 135 days. At 2-4 months, significant improvement in HSS was observed (mean difference 9.50; 95% CI 5.34-13.66; p < 0.001). The 12-month findings (n = 11) suggested possible persistence of benefit but are limited by substantial attrition and symptom-driven follow-up and should not be generalised. The quality-of-life scores (EQ-VAS) showed a 63% improvement between preoperative and 2-4-month values (p < 0.001). No statistically significant improvement was observed at 12 months within the remits of a small symptom-selected sample (n = 11). In total, six patients (11.3%) required subsequent operative intervention. None of the patients who were on anticoagulants had any bleeding complications or any unplanned return to tertiary care. CONCLUSIONS: Our experience demonstrates that radiofrequency ablation treatment for haemorrhoids can be safely and effectively delivered in an outpatient setting under local anaesthesia, even among higher-risk patients. The study demonstrates encouraging short-term symptom improvement, but the limited and selective long-term data preclude firm conclusions regarding durability or broader service impact. Larger, controlled studies with structured long-term follow-up are required to define the role of outpatient RFA within haemorrhoid care pathways.

Techniques in Coloproctology
Mersey Care NHS Trust (GB), Lancashire Care NHS Foundation Trust (GB)
Zero hunger
Openalex Percentile: Top 5%
Anorectal Disease Treatments and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.